# Drug Royalties Fund II LLC — Form D

Drug Royalties Fund II LLC of NEW YORK, NY, a pooled investment fund, filed a Form D exempt-offering notice with the SEC on 2017-12-07. Industry: Pooled Investment Fund.

## Offering

- Filed: 2017-12-07
- Form: D
- Accession: 0001723439-17-000001
- Industry: Pooled Investment Fund
- Exemptions: 06b, 3C, 3C.7
- Security types: fund interests
- Revenue range: Decline to Disclose
- SEC file number: 021-300243

## Issuer

- Name: Drug Royalties Fund II LLC
- CIK: 0001723439
- Entity type: Limited Liability Company
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: 510 MADISON AVENUE, 21ST FLOOR, NEW YORK, NY, 10022
- Phone: 212-257-4750

## Officers, directors & promoters (3)

| Name | Role | Location |
| --- | --- | --- |
| PATRICK L KELLY | Executive Officer | NEW YORK, NY |
| JAMES THOMAS ROTHWELL | Executive Officer | NEW YORK, NY |
| Ross L Stevens | Executive Officer | — |

## More

- [CIK 1723439 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1723439&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001723439-17-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.